Warning letters, 483s, Recalls, Import Alerts, Audit observations
Indian drug regulator, Central Drugs Standard Control Organisation (CDSCO) has issued new directions for stringent
Novo Nordisk’s Bloomington plant (FEI 3005949964, Catalent Indiana LLC) is classified OAI by USFDA in
FDA conducted an inspection at the Hetero Labs Ltd, Warehouse at Nakkapally Village, Vishakapatnam, Andra
Pune based Akriti Pharmaceuticals Private Limited’s EUGMP Certificate remains suspended as the facility remains in
Spurious Drug – Toxic DEG Contamination Reports of child deaths linked to contaminated cough syrups
Amid all the ongoing Tariff Turf War, the U.S. Food and Drug Administration (FDA) has
Janssen Vaccines Corp., a Johnson & Johnson company operating in Korea, was issued an FDA
USP has launched a WhatsApp channel. Through the channel, followers will receive updates in USP
In September 2025, the USFDA classified Sun Pharmaceutical Industries Ltd.’s Halol facility as OAI (Official
Government of India is amending the New Drugs and Clinical Trials (NDCT) Rules 2019 permitting
